Profile | GDS2987 / GI_6631101-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 26.4 | 62 |
GSM215244 | HMVEC_vehicle_rep2 | 10.6 | 27 |
GSM215253 | HMVEC_vehicle_rep3 | 13 | 40 |
GSM215254 | HMVEC_atorvastatin_rep1 | 15 | 37 |
GSM215282 | HMVEC_atorvastatin_rep3 | 22.3 | 46 |
GSM215344 | HMVEC_atorvastatin_rep2 | 22.7 | 48 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 13.1 | 26 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 27.9 | 49 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 34.4 | 49 |
GSM215294 | HMVEC_SLx2119_rep1 | 23.3 | 59 |
GSM215295 | HMVEC_SLx2119_rep2 | 5 | 11 |
GSM215296 | HMVEC_SLx2119_rep3 | 7.8 | 13 |
GSM215297 | PASMC_vehicle_rep1 | 27.3 | 39 |
GSM215298 | PASMC_vehicle_rep2 | 28.7 | 41 |
GSM215310 | PASMC_vehicle_rep3 | 37.9 | 52 |
GSM215311 | PASMC_atorvastatin_rep1 | 43.3 | 59 |
GSM215312 | PASMC_atorvastatin_rep2 | 21.8 | 34 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 50.6 | 64 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 61.6 | 67 |
GSM215327 | PASMC_SLx2119_rep1 | 34.9 | 51 |
GSM215328 | PASMC_SLx2119_rep2 | 38.2 | 55 |
GSM215329 | PASMC_SLx2119_rep3 | 11.8 | 23 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 14.8 | 39 |
GSM215332 | Fibroblasts_vehicle_rep3 | 28 | 61 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 13.8 | 35 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 9.4 | 26 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 20.6 | 45 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 9.6 | 31 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 23.5 | 57 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 21.1 | 50 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 5.9 | 18 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 27.8 | 58 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 40.3 | 64 |